FOR IMMEDIATE RELEASE
Tampa, Florida - Dr. Mildred Acevedo-Duncan, researcher at the University of South Florida Research Foundation, Inc., has been named a recipient of The Aloe Institute’s annual grant funding program. The $15,000 Phase I award was made on the basis of Dr. Acevedo-Duncan’s proposed research project, “In-Vivo Effects of Aloe-Emodin on Nude Mice Glioma Xenografts.” The research will further explore and vali
“We think that this will be a successful approach because we established that aloe-emodin kills brain cancer cells when grown on glass petri dishes in-vitro in the laboratory,” Dr. Acevedo-Duncan says. “Since aloe-emodin is immune-stimulatory [stimulates the immune system] we are hoping that aloe-emodin will stimulate the mice’s immune system to help kill the brain cancer.”
This phase of research moves experiments from the petri dish to a living organism, specifically, the brain of lab mice. “The board of The Aloe Institute chose unanimously to continue Dr. Acevedo-Duncan’s work based on our commitment to funding the most promising research opportunities in the medical community,” says Jane B. Grace, President of The Aloe Institute. “Our charter is the ongoing discovery of new and enhanced medical benefits found only in the aloe plant. Research into cures for cancer, diabetes, high cholesterol and digestive disorders rank highest in our funding priorities,” she adds.
The Aloe Institute is a non-profit organization committed to improving health and wellness globally. The Institute's focus on health and wellness lies in underwriting the most promising aloe research while promoting its clinical and organic benefits through ongoing educational outreach. Information about The Aloe Institute, a summary of current and past research projects and aloe-related information can be found at www.TheAloeInstitute.org.
For more information, contact:
Jane B. Grace
The Aloe Institute
3708 Maplewood Terrace
Bradenton, Florida 34203